Cited by 433Advanced Glycation End Products researchChronic Kidney Disease and DiabetesRenal Diseases and Glomerulopathies

The DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.

Immunohistochemical colocalization of glycoxidation products and lipid peroxidation products in diabetic renal glomerular lesions. Implication for glycoxidative stress in the pathogenesis of diabetic nephropathy.

Open access

Horie, K, Miyata, T, Maeda, K, Miyata, S, Sugiyama, S, Sakai, H, van Ypersole de Strihou, C, Monnier, V M, Witztum, J L, Kurokawa, K·1997·Journal of Clinical Investigation

DOI 10.1172/jci119853PMC PMC508511

Open this paper in CoChat — free account

Abstract

Advanced glycation end products (AGEs) include a variety of protein adducts whose accumulation alters the structure and function of tissue proteins and stimulates cellular responses. They have been implicated in tissue damage associated with diabetic complications. To assess the possible link between AGE accumulation and the development of diabetic nephropathy (DN), we have examined the immunohistochemical localization of various AGE structures postulated to date, i.e., pentosidine, Nepsilon-(carboxymethyl)lysine (CML), and pyrraline, in diabetic and control kidneys. CML and pentosidine accumulate in the expanded mesangial matrix and thickened glomerular capillary walls of early DN and in nodular lesions and arterial walls of advanced DN, but were absent in control kidneys. By contrast, pyrraline was not found within diabetic glomeruli but was detected in the interstitial connective tissue of both normal and diabetic kidneys. Although the distribution of pyrraline was topographically identical to type III collagen, distribution of pentosidine and CML was not specific for collagen type, suggesting that difference in matrix protein composition per se could not explain heterogeneous AGE localization. Since oxidation is linked closely to the formation of pentosidine and CML, we also immunostained malondialdehyde (MDA), a lipid peroxidation product whose formation is accelerated by oxidative stress, assuming that local oxidative stress may serve as a mechanism of pentosidine and CML accumulation. Consistent with our assumption, diabetic nodular lesions were stained positive for MDA. These findings show that AGE localization in DN varies according to AGE structure, and suggest that the colocalization of markers of glycoxidation (pentosidine and CML) with a marker of lipid peroxidation reflects a local oxidative stress in association with the pathogenesis of diabetic glomerular lesions. Thus, glycoxidation markers may serve as useful biomarkers of oxidative damage in DN.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1172/jci119853

Cites

57 of 57 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Role of Oxidative Stress in Development of Complications in Diabetes
Baynes, J. (1991) · Diabetes · doi:10.2337/diab.40.4.405 · Cited by 3,791
Advanced Glycosylation End Products in Tissue and the Biochemical Basis of Diabetic Complications
Flier, J. S., Underhill, L. H., Brownlee, M., Cerami, A., & Vlassara, H. (1988) · New England Journal of Medicine · doi:10.1056/nejm198805193182007 · Cited by 2,512
Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins.
Neeper, M. P., Schmidt, A. M., Brett, J., Yan, S. D., Wang, F., Pan, Y., Elliston, K. O., Stern, D., & SHAW, A. R. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)42138-2 · Cited by 1,545
Enhanced cellular oxidant stress by the interaction of advanced glycation end products with their receptors/binding proteins
Yan, S. D., Schmidt, A. M., Anderson, G. M., Zhang, J., Brett, J., Zou, Y., Pinsky, D. J., & Stern, D. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)36966-1 · Cited by 1,305
Glucose autoxidation and protein modification. The potential role of ‘autoxidative glycosylation’ in diabetes
Wolff, S. P., & Dean, R. T. (1987) · Biochemical Journal · doi:10.1042/bj2450243 · Cited by 1,272
Structure Elucidation of a Senescence Cross-Link from Human Extracellular Matrix
Sell, D. R., & Monnier, V. M. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)88225-8 · Cited by 1,082
Self-citation
Identification of N epsilon-carboxymethyllysine as a degradation product of fructoselysine in glycated protein.
Ahmed, M. U., Thorpe, S. R., & Baynes, J. W. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)89188-3 · Cited by 864
Survey of the distribution of a newly characterized receptor for advanced glycation end products in tissues.
Brett, J., Schmidt, A. M., Yan, S. D., Zou, Y. S., Weidman, E., Pinsky, D. J., Nowygrod, R., Neeper, M. P., Przysiecki, C. T., & SHAW, A. R. (1993) · PubMed · Cited by 780
Hydroxyl radical production and autoxidative glycosylation. Glucose autoxidation as the cause of protein damage in the experimental glycation model of diabetes mellitus and ageing
Hunt, J. V., Dean, R. T., & Wolff, S. P. (1988) · Biochemical Journal · doi:10.1042/bj2560205 · Cited by 779
Accumulation of Maillard reaction products in skin collagen in diabetes and aging.
Dyer, D. G., Dunn, J. A., Thorpe, S. R., Bailie, K., Lyons, T. J., McCance, D. R., & Baynes, J. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116481 · Cited by 770
Antisera and monoclonal antibodies specific for epitopes generated during oxidative modification of low density lipoprotein.
Palinski, W., Ylä‐Herttuala, S., Rosenfeld, M. E., Butler, S. W., Socher, S. S., Parthasarathy, S., Curtiss, L. K., & Witztum, J. L. (1990) · Arteriosclerosis An Official Journal of the American Heart Association Inc · doi:10.1161/01.atv.10.3.325 · Cited by 616
Self-citation
Cachectin/TNF and IL-1 Induced by Glucose-Modified Proteins: Role in Normal Tissue Remodeling
Vlassara, H., Brownlee, M., Manogue, K. R., Dinarello, C. A., & Pasagian, A. (1988) · Science · doi:10.1126/science.3259727 · Cited by 597
Identification of Glyoxal and Arabinose as Intermediates in the Autoxidative Modification of Proteins by Glucose
Wells‐Knecht, K. J., Zyzak, D. V., Litchfield, J., Thorpe, S. R., & Baynes, J. (1995) · Biochemistry · doi:10.1021/bi00011a027 · Cited by 594
Relation between Complications of Type I Diabetes Mellitus and Collagen-Linked Fluorescence
Monnier, V. M., Vishwanath, V., Frank, K. E., Elmets, C. A., Dauchot, P. J., & Kohn, R. R. (1986) · New England Journal of Medicine · doi:10.1056/nejm198602133140702 · Cited by 585
Self-citation
Mechanism of Protein Modification by Glyoxal and Glycolaldehyde, Reactive Intermediates of the Maillard Reaction
Glomb, M. A., & Monnier, V. M. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.17.10017 · Cited by 576
Self-citation
Formation of pentosidine during nonenzymatic browning of proteins by glucose. Identification of glucose and other carbohydrates as possible precursors of pentosidine in vivo
Dyer, D. G., Blackledge, J. A., Thorpe, S. R., & Baynes, J. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)99007-1 · Cited by 535
N.epsilon.-(Carboxymethyl)lysine Is a Dominant Advanced Glycation End Product (AGE) Antigen in Tissue Proteins
Reddy, S., Bichler, J., Wells‐Knecht, K. J., Thorpe, S. R., & Baynes, J. (1995) · Biochemistry · doi:10.1021/bi00034a021 · Cited by 524
Distribution of oxidation specific lipid-protein adducts and apolipoprotein B in atherosclerotic lesions of varying severity from WHHL rabbits.
Rosenfeld, M. E., Palinski, W., Ylä‐Herttuala, S., Butler, S. S., & Witztum, J. L. (1990) · Arteriosclerosis An Official Journal of the American Heart Association Inc · doi:10.1161/01.atv.10.3.336 · Cited by 474
Self-citation
Mechanism of formation of the Maillard protein cross-link pentosidine. Glucose, fructose, and ascorbate as pentosidine precursors
Grandhee, S. K., & Monnier, V. M. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)99006-x · Cited by 459
Self-citation
Retardation by Aminoguanidine of Development of Albuminuria, Mesangial Expansion, and Tissue Fluorescence in Streptozocin-Induced Diabetic Rat
Soulis, T., Cooper, M. E., Papazoglou, D., Clarke, B., & Jerums, G. (1991) · Diabetes · doi:10.2337/diabetes.40.10.1328 · Cited by 446
Maillard reaction products and their relation to complications in insulin-dependent diabetes mellitus.
McCance, D. R., Dyer, D. G., Dunn, J. A., Bailie, K., Thorpe, S. R., Baynes, J., & Lyons, T. J. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116482 · Cited by 444
Nε-(Carboxymethyl)lysine Protein Adduct Is a Major Immunological Epitope in Proteins Modified with Advanced Glycation End Products of the Maillard Reaction
Ikeda, K., Higashi, T., Sano, H., Jinnouchi, Y., Yoshida, M., Araki, T., Ueda, S., & Horiuchi, S. (1996) · Biochemistry · doi:10.1021/bi9530550 · Cited by 434
Amyloid-β peptide–Receptor for Advanced Glycation Endproduct interaction elicits neuronal expression of macrophage-colony stimulating factor: A proinflammatory pathway in Alzheimer disease
Yan, S. D., Zhu, H., Fu, J., Yan, S. F., Roher, A. E., Tourtellotte, W. W., Rajavashisth, T. B., Chen, X., Godman, G. C., Stern, D. M., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.10.5296 · Cited by 429
beta 2-Microglobulin modified with advanced glycation end products is a major component of hemodialysis-associated amyloidosis.
Miyata, T., Oda, O., Inagi, R., Iida, Y., Araki, N., Yamada, N., Horiuchi, S., Taniguchi, N., Maeda, K., & Kinoshita, T. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116696 · Cited by 397
Self-citation
Human neutrophils employ the myeloperoxidase-hydrogen peroxide-chloride system to convert hydroxy-amino acids into glycolaldehyde, 2-hydroxypropanal, and acrolein. A mechanism for the generation of highly reactive alpha-hydroxy and alpha,beta-unsaturated aldehydes by phagocytes at sites of inflammation.
Anderson, M. M., Hazen, S. L., Hsu, F., & Heinecke, J. W. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119176 · Cited by 392
The maillard reaction in aging, diabetes and nutrition
Furth, A. J. (1990) · Trends in Biochemical Sciences · doi:10.1016/0968-0004(90)90040-i · Cited by 373
Advanced protein glycosylation induces transendothelial human monocyte chemotaxis and secretion of platelet-derived growth factor: role in vascular disease of diabetes and aging.
Kirstein, M., Brett, J., Radoff, S., Ogawa, S., Stern, D., & Vlassara, H. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.22.9010 · Cited by 364
Implication of an increased oxidative stress in the formation of advanced glycation end products in patients with end-stage renal failure
Miyata, T., Wada, Y., Cai, Z., Iida, Y., Horie, K., Yasuda, Y., Maeda, K., Kurokawa, K., & de Strihou, C. V. Y. (1997) · Kidney International · doi:10.1038/ki.1997.160 · Cited by 355
Self-citation
Receptor-specific increase in extracellular matrix production in mouse mesangial cells by advanced glycosylation end products is mediated via platelet-derived growth factor.
Doi, T., Vlassara, H., Kirstein, M., Yamada, Y., Striker, G. E., & Striker, L. J. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.7.2873 · Cited by 346
Involvement of beta 2-microglobulin modified with advanced glycation end products in the pathogenesis of hemodialysis-associated amyloidosis. Induction of human monocyte chemotaxis and macrophage secretion of tumor necrosis factor-alpha and interleukin-1.
Miyata, T., Inagi, R., Iida, Y., Sato, M., Yamada, N., Oda, O., Maeda, K., & Seo, H. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117002 · Cited by 343
Self-citation
Pentosidine Formation in Skin Correlates With Severity of Complications in Individuals With Long-Standing IDDM
Sell, D. R., Lapolla, A., Odetti, P. R., Fogarty, J. F., & Monnier, V. M. (1992) · Diabetes · doi:10.2337/diab.41.10.1286 · Cited by 310
Self-citation
Maillard Reaction-Mediated Molecular Damage to Extracellular Matrix and Other Tissue Proteins in Diabetes, Aging, and Uremia
Monnier, V. M., Sell, D. R., Nagaraj, R. H., Miyata, S., Grandhee, S. K., Odetti, P. R., & Ibrahim, S. A. (1992) · Diabetes · doi:10.2337/diab.41.2.s36 · Cited by 309
Self-citation
The receptor for advanced glycation end products (RAGE) is a central mediator of the interaction of AGE-beta2microglobulin with human mononuclear phagocytes via an oxidant-sensitive pathway. Implications for the pathogenesis of dialysis-related amyloidosis.
Miyata, T., Hori, O., Zhang, J., Yan, S. S., Ferran, L., Iida, Y., & Schmidt, A. M. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118889 · Cited by 278
Self-citation
Immunochemical approach to characterize advanced glycation end products of the Maillard reaction
Horiuchi, S., Araki, N., & Morino, Y. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)89449-6 · Cited by 272
Malondialdehyde and 4-hydroxynonenal protein adducts in plasma and liver of rats with iron overload.
Houglum, K., Filip, M., Witztum, J. L., & Chojkier, M. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114934 · Cited by 254
Self-citation
Renal fate of circulating advanced glycated end products (AGE): evidence for reabsorption and catabolism of AGE-peptides by renal proximal tubular cells
Gugliucci, A., & Bendayan, M. (1996) · Diabetologia · doi:10.1007/bf00403957 · Cited by 247
Human and rat mesangial cell receptors for glucose-modified proteins: potential role in kidney tissue remodelling and diabetic nephropathy.
Skolnik, E. Y., Yang, Z., Makita, Z., Radoff, S., Kirstein, M., & Vlassara, H. (1991) · The Journal of Experimental Medicine · doi:10.1084/jem.174.4.931 · Cited by 242
Accumulation of albumin-linked and free-form pentosidine in the circulation of uremic patients with end-stage renal failure
Miyata, T., Ueda, Y., Shinzato, T., Iida, Y., Tanaka, S., Kurokawa, K., de Strihou, C. V. Y., & Maeda, K. (1996) · Journal of the American Society of Nephrology · doi:10.1681/asn.v781198 · Cited by 232
Self-citation
Renal catabolism of advanced glycation end products: the fate of pentosidine
Miyata, T., Ueda, Y., Horie, K., Nangaku, M., Tanaka, S., de Strihou, C. V. Y., & Kurokawa, K. (1998) · Kidney International · doi:10.1046/j.1523-1755.1998.00756.x · Cited by 227
Immunohistochemical detection of advanced glycosylation end products in diabetic tissues using monoclonal antibody to pyrraline.
Miyata, S., & Monnier, V. M. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115690 · Cited by 218
Self-citation
Polyantigenic Expansion of Basement Membrane Constituents in Diabetic Nephropathy
Falk, R. J., Scheinman, J. I., Mauer, S. M., & Michael, A. F. (1983) · Diabetes · doi:10.2337/diab.32.2.s34 · Cited by 206
Identification of pentosidine as a native structure for advanced glycation end products in beta-2-microglobulin-containing amyloid fibrils in patients with dialysis-related amyloidosis.
Miyata, T., Taneda, S., Kawai, R., Ueda, Y., Horiuchi, S., Hara, M., Maeda, K., & Monnier, V. M. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.6.2353 · Cited by 191
Self-citation
Increased collagen-linked pentosidine levels and advanced glycosylation end products in early diabetic nephropathy.
Beisswenger, P. J., Moore, L. L., Brinck‐Johnsen, T., & Curphey, T. J. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116552 · Cited by 172
Reaction of ascorbate with lysine and protein under autoxidizing conditions: formation of N.epsilon.-(carboxymethyl)lysine by reaction between lysine and products of autoxidation of ascorbate
Dunn, J. A., Ahmed, M. U., Murtiashaw, M. H., Richardson, J. M., Walla, M. D., Thorpe, S. R., & Baynes, J. (1990) · Biochemistry · doi:10.1021/bi00501a014 · Cited by 170
Pathways of Formation of Glycoxidation Products during Glycation of Collagen
Wells-Knecht, M. C., Thorpe, S. R., & Baynes, J. (1995) · Biochemistry · doi:10.1021/bi00046a020 · Cited by 155
Improvement of blood glucose control in IDDM patients retards the progression of morphological changes in early diabetic nephropathy
Bangstad, H. ‐., Dahl‐Jørgensen, K., Hanssen, K. F., Østerby, R., Berg, K. J., & Hartmann, A. (1994) · Diabetologia · doi:10.1007/s001250050136 · Cited by 147
Toward a Maillard reaction theory of aging.
Monnier, V. M. (1989) · PubMed · Cited by 142
Self-citation
Detection of d-glucose-derived pyrrole compounds during maillard reaction under physiological conditions
Njoroge, F. G., Sayre, L. M., & Monnier, V. M. (1987) · Carbohydrate Research · doi:10.1016/0008-6215(87)80280-x · Cited by 129
Self-citation
Perspectives in Diabetes Role of Oxidative Stress in Development of Complications in Diabetes
Baynes, J. (1991) · Cited by 103
The Role of Reactive Oxygen Species in Animal Models of Glomerular Disease
Diamond, J. R. (1992) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(13)80013-3 · Cited by 99
β2-Microglobulin Modified with Advanced Glycation End Products Induces Interleukin-6 from Human Macrophages: Role in the Pathogenesis of Hemodialysis-Associated Amyloidosis
Iida, Y., Miyata, T., Inagi, R., Sugiyama, S., & Maeda, K. (1994) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1994.1837 · Cited by 90
Self-citation
Role of oxidants and proteases in glomerular injury
Johnson, R. J., Lovett, D. H., Lehrer, R. I., Couser, W. G., & Klebanoff, S. J. (1994) · Kidney International · doi:10.1038/ki.1994.45 · Cited by 90
Chromatographic evidence for pyrraline formation during protein glycation in vitro and in vivo
Portero‐Otín, M., Nagaraj, R. H., & Monnier, V. M. (1995) · Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology · doi:10.1016/0167-4838(94)00209-y · Cited by 86
Self-citation
Monocyte/macrophage response to β2-microglobulin modified with advanced glycation end products
Miyata, T., Iida, Y., Ueda, Y., Shinzato, T., Seo, H., Monnier, V. M., Maeda, K., & Wada, Y. (1996) · Kidney International · doi:10.1038/ki.1996.77 · Cited by 86
Self-citation
Occurrence of Type VI Collagen in Extracellular Matrix of Renal Glomeruli and Its Increase in Diabetes
Mohan, P. S., Carter, W. G., & Spiro, R. G. (1990) · Diabetes · doi:10.2337/diacare.39.1.31 · Cited by 65
Localization of Fibril/Microfibril and Basement Membrane Collagens in Diabetic Glomerulosclerosis in Type 2 Diabetes
Makino, H., Shikata, K., Wieslander, J., Wada, J., Kashihara, N., Yoshioka, K., & Ota, Z. (1994) · Diabetic Medicine · doi:10.1111/j.1464-5491.1994.tb00276.x · Cited by 33
Occurrence of type VI collagen in extracellular matrix of renal glomeruli and its increase in diabetes
Mohan, P. S., Carter, W. G., & Spiro, R. G. (1990) · Diabetes · doi:10.2337/diabetes.39.1.31 · Cited by 26

Flagged first, then by citations

Sorted by citations

Biochemistry and molecular cell biology of diabetic complications
Brownlee, M. (2001) · Nature · doi:10.1038/414813a · Cited by 9,107
Oxidative stress and diabetic complications
Giacco, F., & Brownlee, M. (2010) · Circulation Research · doi:10.1161/circresaha.110.223545 · Cited by 5,461
Role of oxidative stress in diabetic complications: a new perspective on an old paradigm.
Baynes, J. W., & Thorpe, S. R. (1999) · Diabetes · doi:10.2337/diabetes.48.1.1 · Cited by 2,441
Diabetic kidney disease
Thomas, M. C., Brownlee, M., Suszták, K., Sharma, K., Jandeleit-Dahm, K. A. M., Zoungas, S., Rossing, P. R., Groop, P., & Cooper, M. E. (2015) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2015.18 · Cited by 1,335
N ε-(Carboxymethyl)Lysine Adducts of Proteins Are Ligands for Receptor for Advanced Glycation End Products That Activate Cell Signaling Pathways and Modulate Gene Expression
Kislinger, T., Fu, C., Huber, B., Qu, W., Taguchi, A., Yan, S. D., Hofmann, M. A., Yan, S. F., Pischetsrieder, M., Stern, D. M., et al. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.44.31740 · Cited by 868

See all 433

Authors: Horie, K., Miyata, T., Maeda, K., Miyata, S., Sugiyama, S., Sakai, H., van Ypersole de Strihou, C., Monnier, V. M., Witztum, J. L., & Kurokawa, K.
Affiliations: Nagoya University (JP)
Tokai University (JP)
Kobe University (JP)
Chukyo Hospital (JP)
Case Western Reserve University (US)
University of California San Diego (US)
ORCID: Miyata, T
Maeda, K
Miyata, S
Sugiyama, S
Monnier, V M
Kurokawa, K
Venue: Journal of Clinical Investigation
Publisher: American Society for Clinical Investigation
Published: 1997-12-15
Volume: 100
Issue: 12
Pages: 2995-3004
ISSN: 0021-9738 (ISSN-L)
DOI: 10.1172/jci119853
PMC: PMC508511
OpenAlex: W2085341182
Cited by: 433
References: 56
Citations by year: 2026: 3 · 2025: 8 · 2024: 5 · 2023: 7 · 2022: 9 · 2021: 14 · 2020: 10 · 2019: 10 · 2018: 7 · 2017: 12 · 2016: 10 · 2015: 8 · 2014: 14 · 2013: 9 · 2012: 15
FWCI: 14.04
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Locations: Journal of Clinical Investigation (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
DIAL (Catholic University of Leuven) (submittedVersion, other-oa)
Funders: Japan Society for the Promotion of Science (96L00303)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Advanced Glycation End Products research
Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
Health Sciences › Medicine › Nephrology › Renal Diseases and Glomerulopathies
Keywords: advanced glycation end products, glycoxidation, lipid peroxidation, diabetic nephropathy, pentosidine, carboxymethyllysine, pyrraline, malondialdehyde, oxidative stress, glomerular lesions, mesangial matrix, type III collagen, oxidative damage biomarkers
MeSH terms: Adolescent, Adult, Aged, Animals, Antibodies, Arginine, Collagen, Diabetes Mellitus, Type 2, Diabetic Nephropathies, Female, Humans, Immunoenzyme Techniques, Kidney Glomerulus, Lysine, Male, Malondialdehyde, Middle Aged, Nephrotic Syndrome, Norleucine, Pyrroles, Rabbits, Lipid Peroxidation, Glycation End Products, Advanced, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Immunohistochemical colocalization of glycoxidation products and lipid peroxidation products in diabetic renal glomerular lesions. Implication for glycoxidative stress in the pathogenesis of diabetic nephropathy.

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks